newsfilter
← Latest News
PR Newswire·

Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered ...